| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308514 | Kidney International | 2005 | 5 Pages |
Abstract
The purpose of this presentation is to provide an overview of the role of the CASR in regulation of parathyroid gland function, to examine the mechanisms whereby calcimimetics target the CASR, and to review the clinical trials that support the use of cinacalcet HCl for the treatment of secondary hyperparathyroidism in stage 5 chronic kidney disease (CKD).
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
L. Darryl Quarles,